DNA-scaffolded biomaterials enable modular and tunable control of - - PowerPoint PPT Presentation

dna scaffolded biomaterials enable modular and tunable
SMART_READER_LITE
LIVE PREVIEW

DNA-scaffolded biomaterials enable modular and tunable control of - - PowerPoint PPT Presentation

The 16 th US-Korea Forum on Nanotechnology DNA-scaffolded biomaterials enable modular and tunable control of immune cell therapies Xiao Huang, PhD Postdoc Scholar, Desai Lab University of California San Francisco CAR-T therapy


slide-1
SLIDE 1

DNA-scaffolded biomaterials enable modular and tunable control of immune cell therapies

Xiao Huang, PhD Postdoc Scholar, Desai Lab University of California San Francisco

The 16th US-Korea Forum

  • n Nanotechnology
slide-2
SLIDE 2

CAR-T therapy – revolutionary cancer therapy

CANCER CELL

T CELL

CD19 CAR

Brown & Mackall. Nature Reviews Immunology, 2019

slide-3
SLIDE 3

Lim & June. Cell, 2017

Efficacy and safety are critical aspects for cancer therapy

On-tumor efficacy Off-tumor safety

slide-4
SLIDE 4

Biomaterials can modulate immune cell behaviors

TUMOR EFFICACY Regulatory signals

P

SAFETY TUMOR

ON

NORMAL

Riley, et al. Nature Reviews Drug Discovery, 2019

Immune cell engaging particles (ICEp)

slide-5
SLIDE 5

ATGCGCTACATGCTCTC

DNA scaffolds on biomaterials allows efficient loading and precise control of functional proteins

Unmatch Match

RT 2 mins

FAST

R strand : G strand : B strand Input 3:1:1 Input 1:1:1 Input 1:1:3

5𝛎m

VERSATILE EFFICIENT

5 10 15 20 25 IgG loading on PLGA microparticles (nM/OD550) DNA- Low DNA- Medium DNA- High T r a d i t i

  • n

a l

Theoretical Footprint Limit

slide-6
SLIDE 6

ICEp can provide unique opportunities for boosting of immune cell efficacy

Co-stimulatory signals Cytokines Checkpoint inhibitors Adjuvants Antigens …

P

ICEp-𝛃-CD3/𝛃- CD28

T

CD3/CD28 Human primary T cells

CD4+ T CD8+ T

[1:5] [1:3] [1:1] [3:1] [5:1] 2×106 5.0×106 1.0×107 1.5×107 2.0×107 2.5×107 4×107 CD4+ T cell number at day 14

P = 0.0153

[1:5] [1:3] [1:1] [3:1] [5:1] 5×106 1×107 1.2×107 1.6×107 2.0×107 2.4×107 2.8×107 3.2×107 CD8+ T cell number at day 14

P = 0.0115

day 0 = 1.4x105

slide-7
SLIDE 7

Local activation of AND-gate CAR-T cells by ICEp to enhance safety

P

CAR

TF

  • 1. Roybal, et al. Cell, 2016
  • 2. Huang, et al. BioRxiv, 2019

20 40 60 80 % Target killing by CD8+ T No ICEp Traditional chemistry GFP density

slide-8
SLIDE 8

NSG mice dual tumor model for local CAR-T cell activation

4 8 12 16 600 1200 1800 2400

P = 0.5166 P = 0.6595 (n = 8) (n = 8)

Without ICEp With ICEp 4 8 12 16 600 1200 1800 2400

(n=6) P = 0.3092 P = 0.0075 P = 0.0032 (n=8) (n=8)

Tumor volume (mm3)

SynNotch CAR-T Untransduced T

Day after T cell injection

Huang, et al. BioRxiv, 2019

slide-9
SLIDE 9

Acknowledgements

  • Dr. Tejal Desai
  • Dr. Ryan Chang

Zhongbo Li Desai lab members

  • Dr. Wendell Lim
  • Dr. Jasper Williams
  • Dr. Wei Yu
  • Dr. David Patterson

PBBR

Thank you!